-
Glenmark pledges 50 lakh meals for the needy amidst COVID-19 pandemic
expresspharma
April 24, 2020
Additionally over 3,00,000 beneficiaries to be reached across Himachal Pradesh, Madhya Pradesh and Gujarat via tele-medicine by medical specialists.
-
4D pharma to initiate Phase II study of MRx-4DP0004 to treat COVID-19
europeanpharmaceuticalreview
April 23, 2020
The UK MHRA granted expedited acceptance for the Phase II trial of MRx-4DP0004, a live biotherapy product and targeted immunomodulatory therapy.
-
Developing a COVID-19 biosensor for faster diagnostics and environmental monitoring
europeanpharmaceuticalreview
April 23, 2020
A team have developed a biosensor with high specificity and sensitivity for COVID-19 that could be used in hospitals, train stations or laboratories to detect SARS-CoV-2.
-
SOM Biotech identifies three Covid-19 drug candidates
pharmaceutical-technology
April 23, 2020
SOM Biotech has completed in-vitro analyses and identified three drug candidates that can be potentially used to treat Covid-19.
-
Real-world evidence the most impactful emerging technology in COVID-19 management: Poll
pharmaceutical-technology
April 23, 2020
New-age emerging technologies are projected to have a significant impact on managing the coronavirus pandemic (COVID-19).
-
NIH panel warns against use of hydroxychloroquine to treat Covid-19
pharmaceutical-technology
April 23, 2020
A US National Institutes of Health (NIH) panel has recommended against the use of hydroxychloroquine in combination with azithromycin as a Covid-19 treatment.
-
Lack of awareness among patients the biggest challenge to wider adoption of telemedicine: Poll
pharmaceutical-technology
April 23, 2020
Telemedicine has witnessed an increased usage during the COVID-19 pandemic but challenges remain for its widespread adoption.
-
MIT researchers in US advance Covid-19 vaccine into preclinical tests
pharmaceutical-technology
April 23, 2020
A research team at the Massachusetts Institute of Technology (MIT) in the US have advanced a Covid-19 vaccine candidate into preclinical tests in animal models.
-
Pharnext, UHI to Evaluate Repurposed Drugs Against COVID-19
contractpharma
April 23, 2020
Aims to rapidly test several approved drugs as potential candidates for fighting COVID-19 using big data and artificial intelligence.
-
Q BioMed, Mannin Research Accelerate COVID-19 Response Initiatives
contractpharma
April 23, 2020
Leveraging Mannin’s Tie2 based small molecule platform to address vascular leakage, a life-threatening COVID-19 complication.